RecruitingPhase 3NCT07116967
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Sponsor: Bristol-Myers Squibb
Omaha, NE · +121 more sites
2 recruiting psoriasis studies with a site in Omaha, NE.
Sponsor: Bristol-Myers Squibb
Omaha, NE · +121 more sites
Sponsor: University of Pennsylvania
Omaha, NE · +13 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.